OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort
Javier Vázquez‐Bourgon, Marcos Gómez‐Revuelta, Jacqueline Mayoral-van Son, et al.
European Psychiatry (2022) Vol. 65, Iss. 1
Open Access | Times Cited: 13

Showing 13 citing articles:

Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review
Lizeth Sepúlveda-Lizcano, Vivian Vanessa Arenas-Villamizar, Enna Beatriz Jaimes-Duarte, et al.
European Journal of Investigation in Health Psychology and Education (2023) Vol. 13, Iss. 8, pp. 1505-1520
Open Access | Times Cited: 26

Weight and metabolic changes in early psychosis―association with daily quantification of medication exposure during the first hospitalization
Kristýna Vochosková, Sean R. McWhinney, Markéta Fialová, et al.
Acta Psychiatrica Scandinavica (2023) Vol. 148, Iss. 3, pp. 265-276
Open Access | Times Cited: 11

Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian Biobank
Maris Alver, Silva Kasela, Liina Haring, et al.
The Lancet Regional Health - Europe (2024) Vol. 41, pp. 100914-100914
Open Access | Times Cited: 4

Schizophrenia and Related Psychoses

(2025), pp. 1-278
Closed Access

Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia
Myung A. Lee, Philip A. Cola, Karu Jayathilake, et al.
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 3, pp. 211-219
Closed Access | Times Cited: 7

Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis
Javier Vázquez‐Bourgon, Víctor Ortiz‐García de la Foz, Marcos Gómez‐Revuelta, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 25, Iss. 10, pp. 795-806
Open Access | Times Cited: 10

A Review of Cardiovascular Risk Factors in Women with Psychosis
Alexandre González-Rodríguez, Mary V. Seeman, Armand Guàrdia, et al.
Women (2023) Vol. 3, Iss. 2, pp. 200-213
Open Access | Times Cited: 4

Psychosis metabolic risk calculator (PsyMetRiC) in early psychosis: External validation study in Finland
Jaakko Keinänen, Saana Eskelinen, Tiina From, et al.
Acta Psychiatrica Scandinavica (2024) Vol. 151, Iss. 1, pp. 56-68
Open Access | Times Cited: 1

Langzeitverläufe bei Schizophrenien
Igor Nenadić, Irina Falkenberg, Stephanie Mehl, et al.
Der Nervenarzt (2024)
Open Access

A retrospective database study on 2-year weight trajectories in first-episode psychosis
Yi Chian Chua, Edimansyah Abdin, Charmaine Tang
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 1

30-year cardiovascular disease risk for young adults with serious mental illness
Kathleen Miley, Stephanie Ann Hooker, A. Lauren Crain, et al.
General Hospital Psychiatry (2023) Vol. 85, pp. 139-147
Closed Access | Times Cited: 1

Page 1

Scroll to top